June 13, 2025

JAK Inhibitors Show No Increased Cancer Risk

New real-world data show no significant rise in overall cancer incidence with JAK inhibitors for rheumatoid arthritis patients, though skin cancer monitoring remains important.

Conexiant

June 10, 2025

FDA OCE Announces Project Interface Outreach Initiative

The Oncology Center of Excellence (OCE) at the FDA has launched Project Interface to advance engagement and outreach to patients with cancer, advocacy organizations, and oncology experts. Its mission ...

The ASCO Post

June 10, 2025

Does Combination Therapy Improve Albuminuria?

Finerenone plus empagliflozin reduced urinary albumin-to-creatinine ratio by 29% to 32% more than either drug alone in patients with chronic kidney disease and type 2 diabetes.

Conexiant

June 10, 2025

Does Autism-Linked Cortical Noise Impair Sleep?

New research presented at SLEEP 2025 links increased auditory cortex excitability with poor sleep efficiency in children—especially those with autism spectrum disorder—offering insight into sensory-driven sleep disturbances.

Conexiant

June 10, 2025

New Tool May Identify Patients at High Risk of Developing RA

New criteria may aid in identifying patients with joint pain who are at high risk of developing rheumatoid arthritis, enabling earlier intervention and better trial recruitment.

Conexiant

June 09, 2025

AI: Superpower or Kryptonite? Cardiac Expert Weighs In

Artificial intelligence has arrived in medicine. Yet is it amplifying your clinical expertise or subtly undermining your patient care?

Baptist Health South Florida

June 09, 2025

Sleep Signals May Shape Survival Odds

A new study found that a shorter time gap between melatonin production and sleep midpoints may be linked to longer survival among women with advanced breast cancer.

Conexiant

June 09, 2025

Postpartum Sleep Stays Fragmented for 13 Weeks

New research found that first-time mothers experienced substantial sleep disruption for more than 3 months after childbirth, even as total sleep time gradually recovered.

Conexiant

June 06, 2025

Can At-Home Melatonin Testing Work?

At-home dim light melatonin onset assessments were 92% successful in youth with ADHD symptoms, regardless of symptom severity.

Conexiant